Increased orders for Covance quells LabCorp uncertainty, says analyst
Covance’s 5% revenue growth and a book-to-bill ratio of 1.3 for the fourth quarter 2014 was better than anticipated and an encouraging sign for LabCorp, an analyst says.
Archives for February 4, 2015
Inhaled insulin: Sanofi alone as Big Pharma declines to revisit past
Pfizer, Lilly and Novo Nordisk will not be revisiting inhaled insulin opportunities despite the US launch and expected success of Sanofi and MannKind’s Afrezza.
Vertellus buys antiretroviral API reagent plant from Dow
Specialty chemicals firm Vertellus will continue to supply antiretroviral drugmakers sodium borohydride following its takeover of a Dow plant in Washington State.
Think you’re on track for 2018 EU serialisation? No you’re not
Most pharmaceutical companies are already behind on preparations for the EU Falsified Medicines Directive’s serialisation requirements for 2018, says one services firm.
Two Indian manufacturers cited by FDA for data integrity issues
Bangalore, India-based Apotex and Verna, India-based Micro Labs both received warning letters last month from the US FDA detailing data integrity questions linked to their quality systems.
UPDATE: Merck says switching cell lines would impact safety and quality
Anti-abortion group won't judge parents who choose Merck & Co's MMR vaccine
The anti-abortion group that blames Merck & Co for the recent US measles outbreak says it would not judge parents who have children vaccinated with MMR II for the good of society.
CRO genae acquires e-novex EDC technology
Belgian medical device CRO genae associates has acquired e-novex, a provider of electronic data tools for medical research.